- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Basis of Class A β-Lactamase Inhibition by Relebactam
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 63, Issue 10, Pages -
Publisher
American Society for Microbiology
Online
2019-08-05
DOI
10.1128/aac.00564-19
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interplay between β-lactamases and new β-lactamase inhibitors
- (2019) Karen Bush et al. NATURE REVIEWS MICROBIOLOGY
- Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
- (2019) Peera Hemarajata et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular Basis for the Potent Inhibition of the Emerging Carbapenemase VCC-1 by Avibactam
- (2019) Chand S. Mangat et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inactivation of the Pseudomonas-Derived Cephalosporinase-3 (PDC-3) by Relebactam
- (2018) Melissa D. Barnes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relebactam Is a Potent Inhibitor of the KPC-2 β-Lactamase and Restores Imipenem Susceptibility in KPC-Producing Enterobacteriaceae
- (2018) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multiscale Simulations of Clavulanate Inhibition Identify the Reactive Complex in Class A β-Lactamases and Predict the Efficiency of Inhibition
- (2018) Rubén A. Fritz et al. BIOCHEMISTRY
- Strategic Approaches to Overcome Resistance against Gram-Negative Pathogens Using β-Lactamase Inhibitors and β-Lactam Enhancers: Activity of Three Novel Diazabicyclooctanes WCK 5153, Zidebactam (WCK 5107), and WCK 4234
- (2018) Krisztina M. Papp-Wallace et al. JOURNAL OF MEDICINAL CHEMISTRY
- DIALS: implementation and evaluation of a new integration package
- (2018) Graeme Winter et al. Acta Crystallographica Section D-Structural Biology
- Acquisition of Extended-Spectrum β-Lactamase GES-6 Leading to Resistance to Ceftolozane-Tazobactam Combination in Pseudomonas aeruginosa
- (2018) Laurent Poirel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2)
- (2017) Orville A. Pemberton et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates
- (2017) Karina Calvopiña et al. MOLECULAR MICROBIOLOGY
- Reversibility of Covalent, Broad-Spectrum Serine β-Lactamase Inhibition by the Diazabicyclooctenone ETX2514
- (2017) Adam B. Shapiro et al. ACS Infectious Diseases
- ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
- (2017) Thomas F. Durand-Réville et al. Nature Microbiology
- Sideromimic Modification of Lactivicin Dramatically Increases Potency against Extensively Drug-Resistant Stenotrophomonas maltophilia Clinical Isolates
- (2016) Karina Calvopiña et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New β-Lactamase Inhibitors in the Clinic
- (2016) Krisztina M. Papp-Wallace et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Investigations on recyclisation and hydrolysis in avibactam mediated serine β-lactamase inhibition
- (2016) Hwanho Choi et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Variants of β-Lactamase KPC-2 That Are Resistant to Inhibition by Avibactam
- (2015) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of Klebsiella pneumoniae Carbapenemase Subtypes, Extended-Spectrum β-Lactamases, and Porin Mutations on theIn VitroActivity of Ceftazidime-Avibactam against Carbapenem-Resistant K. pneumoniae
- (2015) Ryan K. Shields et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Stenotrophomonas, Achromobacter, and Nonmelioid Burkholderia Species: Antimicrobial Resistance and Therapeutic Strategies
- (2015) Anton Peleg et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability
- (2015) Shrenik C. Mehta et al. PLoS Pathogens
- Molecular Mechanism of Avibactam-Mediated β-Lactamase Inhibition
- (2015) Dustin T. King et al. ACS Infectious Diseases
- Inhibition of Klebsiella β-Lactamases (SHV-1 and KPC-2) by Avibactam: A Structural Study
- (2015) Nikhil P. Krishnan et al. PLoS One
- Reclaiming the Efficacy of β-Lactam–β-Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime
- (2014) Krisztina M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Kinetic and Structural Requirements for Carbapenemase Activity in GES-Type β-Lactamases
- (2014) Nichole K. Stewart et al. BIOCHEMISTRY
- Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
- (2014) Timothy A. Blizzard et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Decision making inxia2
- (2013) Graeme Winter et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Structural Insight into Potent Broad-Spectrum Inhibition with Reversible Recyclization Mechanism: Avibactam in Complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-Lactamases
- (2013) Sushmita D. Lahiri et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Kinetics of Avibactam Inhibition against Class A, C, and D β-Lactamases
- (2013) David E. Ehmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NXL104 Irreversibly Inhibits the β-Lactamase from Mycobacterium tuberculosis
- (2012) Hua Xu et al. BIOCHEMISTRY
- Exploring the Role of a Conserved Class A Residue in the Ω-Loop of KPC-2 β-Lactamase
- (2012) Peter S. Levitt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Avibactam is a covalent, reversible, non- -lactam -lactamase inhibitor
- (2012) D. E. Ehmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTX-M Enzymes: Origin and Diffusion
- (2012) Rafael Cantón et al. Frontiers in Microbiology
- Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria
- (2011) Ryan S. Arnold et al. SOUTHERN MEDICAL JOURNAL
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Three Decades of -Lactamase Inhibitors
- (2010) S. M. Drawz et al. CLINICAL MICROBIOLOGY REVIEWS
- Elucidating the role of Trp105 in the KPC-2 β-lactamase
- (2010) Krisztina M. Papp-Wallace et al. PROTEIN SCIENCE
- Inhibitor Resistance in the KPC-2 -Lactamase, a Preeminent Property of This Class A -Lactamase
- (2009) K. M. Papp-Wallace et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Updated Functional Classification of -Lactamases
- (2009) K. Bush et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A -Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France
- (2008) S. Petrella et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Phenotypic and Enzymatic Comparative Analysis of the Novel KPC Variant KPC-5 and Its Evolutionary Variants, KPC-2 and KPC-4
- (2008) D. J. Wolter et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search